Skip to main content
. 2021 Mar;10(3):892–900. doi: 10.21037/gs-20-783

Table 2. Treatment details and postoperative outcomes.

Parameter Value
Perioperative haemodynamic instability, n (%) 42 (43.8)
Mean operative time (min), mean ± SD 98.7±41.7
Mean anaesthesia duration (min), mean ± SD 137.5±44.2
Patients needing blood transfusion, n (%) 8 (8.3)
Mean intraoperative blood loss (mL), mean ± SD 165.7±381.2
Fluid management
   Intraoperative (mL), mean ± SD [median] 1,594.7±674.9 [1,500]
   During the first 24 h (mL), mean ± SD [median] 2,786.8±1,052.4 [3,000]
Intraoperative use of vasodilators, n (%) 42 (43.8)
Intraoperative use of vasopressors, n (%) 17 (17.7)
Intraoperative systolic blood pressure
   Patients with episodes SBP >200 mmHg, n (%) 24 (25.0)
   Duration (min), mean ± SD [median] 17.8±17.2 [10]
   Patients with episodes SBP >180 mmHg, n (%) 40 (41.7)
   Duration (min), mean ± SD [median] 17.3±16.3 [10]
   Patients with episodes SBP >160 mmHg, n (%) 60 (62.5)
   Duration (min), mean ± SD [median] 26.7±26.9 [15]
Postoperative use of vasopressors, n (%) 18 (18.8)
Complications, n (%) 25 (26.0)
   Clavien-Dindo 1 4 (4.2)
   Clavien-Dindo 2 16 (16.7)
   Clavien-Dindo 3 1 (1.0)
   Clavien-Dindo 4 3 (3.1)
   Clavien-Dindo 5 1 (1.0)
Mean length of hospital stay, days, mean, mean ± SD [median] 3.5±2.2 [3]

SD, standard deviation; SBP, systolic blood pressure.